Finance

Beta
Lists
EMBC:NASDAQ
Embecta Corp
$3.38
-0.88%
(-0.030) 1D
$3.35
-0.89% (-0.030)
Pre-market
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EMBC...
Open
$3.40
High
$3.48
Low
$3.37
Mkt. cap
200.53M
Avg. vol.
3.00M
Volume
692.00
Dividend
1.18%
Quarterly dividend
$0.01
Ex-dividend date
May 28, 2026
P/E ratio
1.78
52-wk high
$15.55
52-wk low
$2.77
EPS
$1.90
Beta
0.81
Shares outstanding
59.33M
No. of employees
2K
Open
$3.40
High
$3.48
Low
$3.37
Mkt. cap
200.53M
Avg. vol.
3.00M
Volume
692.00
Dividend
1.18%
Quarterly dividend
$0.01
Ex-dividend date
May 28, 2026
P/E ratio
1.78
52-wk high
$15.55
52-wk low
$2.77
EPS
$1.90
Beta
0.81
Shares outstanding
59.33M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to EMBC in the past 3 months
Sell
Buy
0
Hold
2
Sell
1
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for EMBC in the last 3 months.
Highest
Current $3.38
$5.00 (+47.93%)
Average
$4.00 (+18.34%)
Lowest
$3.00 (-11.24%)
News stories
From sources across the web
About Embecta Corp
CEO-
Employees1.85K
Founded1924
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorMedical device
Last report
May 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.27 / $0.42
-35.33%miss
Revenue / Est. (USD)
221.80M / 235.66M
-5.88%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
295.50M
264.00M
261.20M
221.80M
Cost of goods sold
98.10M
105.40M
99.50M
94.00M
Cost of revenue
98.10M
105.40M
99.50M
94.00M
Research and development expenses
3.80M
4.60M
4.60M
5.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
84.40M
86.90M
77.60M
76.20M
Operating expense
92.70M
93.00M
85.40M
84.90M
Total operating expenses
190.80M
198.40M
184.90M
178.90M
Operating income
104.70M
65.60M
76.30M
42.90M
Other non operating income
4.80M
-2.60M
-300.00K
-2.90M
EBT including unusual items
72.20M
29.00M
58.90M
9.50M
EBT excluding unusual items
82.90M
38.10M
51.90M
17.40M
Income tax expense
26.70M
2.60M
14.80M
13.60M
Effective tax rate
36.98%
8.97%
25.13%
143.16%
Other operating expenses
4.50M
1.50M
3.20M
3.30M
Net income
45.50M
26.40M
44.10M
-4.10M
Net profit margin
15.40%
10.00%
16.88%
-1.85%
Earnings per share
1.12
0.50
0.71
0.27
Interest and investment income
-
6.00M
900.00K
700.00K
Interest expense
-26.60M
-32.10M
-25.00M
-23.30M
Net interest expenses
-26.60M
-26.10M
-24.10M
-22.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
113.90M
78.70M
86.60M
53.10M
Gain or loss from assets sale
-
-
-10.10M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more